Ghosh et al Synergism between Tat and VP16 in Trans-activation of HIV-1 LTR. Journal of Molecular Biology (1993) Vo. 234, pp. 610-619.* |
Gossen et al. “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters” Proc. Natl. Acad. Sci., USA 89:5547-5551 (1992). |
Adachi et al. “Production of Acquired Immunodeficiency Syndrome-Associated Retrovirus in Human and Nonhuman Cells Transfected with an Infectious Molecular Clone” Journal of Virology 59(2):284-291 (1986). |
Chang et al. “Regulation by HIV Rev Depends Upon Recognition of Splice Sites” Cell 59:789-795 (1989). |
Chang et al. “The Basic RNA-Binding Domain of HIV-2 Tat Contributes to Preferential Trans-Activation of a TAR2-Containing LTR” Nucleic Acids Research 20(20):5465-5472 (1992). |
Hammarskjold et al. “Human Immunodeficiency Virus env Expression Becomes Rev-Independent If the env Region Is Not Defined as an Intron” Journal of Virology 68(2):951-958 (1994). |
Katri et al. “A Packaging Cell Line for Lentivirus Vectors” Journal of Virology 73(1):576-584 (1999). |
Klages et al. A Stable System for the High-Titer Production of Multiply Attenuated Lentiviral. |
Yu et al. “Inducible Human Immunodeficiency Virus Type 1 Packaging Cell Lines” Journal of Virology 70(7):4530-4537 (1996). |
International Search Report, mailed on Oct. 27, 2003, for PCT patent application No. PCT/US02/34932, filed on Oct. 30, 2002, 4 pages. |